A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523587-20-00

Acronym

HP6019-07

Enrollment

Registered

2025-12-19

Start date

2026-01-05

Completion date

Unknown

Last updated

2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Not applicable for phase I study

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026